Comparative evaluation of hydroquinone, tretinoin and mometasone versus glycolic acid versus trichloroacetic acid peel in melasma

Authors

  • Seeba Hussain Department of Dermatology, Venereology and Leprosy, Katihar Medical College, Katihar, India
  • Md Raihan Department of Dermatology, Venereology and Leprosy, Rama Medical College, Ghaziabad, India
  • Abhijeet Kumar Jha Department of Dermatology, STD and Leprosy, All India Institute of Medical Sciences, Patna, Bihar, India
  • Satyaki Ganguly Department of Dermatology and Venereology, Pondicherry Institute of Medical Sciences, Pondicherry, India
  • Kranti Chandan Jaykar Department of Dermatology, Indra Gandhi Institute of Medical Sciences, Patna, India
  • Paritosh Kumar Banerjee Department of Dermatology, Venereology and Leprosy, Katihar Medical College, Katihar, India

DOI:

https://doi.org/10.66344/jpad.v26i1.71

Keywords:

Melasma, hydroquinone, tretinoin, mometasone, glycolic acid, trichloroacetic acid

Abstract

Objective Comparative evaluation of 2% hydroquinone, 0.025% tretinoin and 1% mometasone versus glycolic acid and trichloroacetic acid peel alone in melasma.

 

Methods Seventy five patients were included in the study. Total duration of study was one and a half years. Melasma area severity index (MASI) score of more than 10 were included in the study. The patients were divided into three groups. Group A consisted of 25 patients and were given 2% Hydroquinone, mometasone 1% and 0.025% tretinoin. Group B consisted of 25 patients and underwent glycolic acid peel. Group C consisted of 25 patients and underwent trichloroacetic acid peel.

 

Results Group A had better response, followed by group B and group C, respectively.

 

Conclusion Combination of hydroquinone, mometasone and tretinoin is a good option to treat melasma only when used judiciously along with sunscreen, whereas glycolic acid peels are a safer option with fewer side effects.

 

References

1. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25:343-52.

2. Vázquez M, Maldonado H, Benmamán C, Sánchez JL. Melasma in men: A clinical and histological study. Int J Dermatol. 1988;27:25-7.

3. Pérez M, Sánchez JL, Aguiló F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol. 1983;81:543-5.

4. Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22:443-7.

5. Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol. 1997;36:589-93.

6. Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol. 1998;37:897-903.

7. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-8.

8. Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001;40:354-7.

9. Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol. 2002;138:1578-82.

10. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15:894-9.

11. Chun EY, Lee JB, Lee KH. Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients. Dermatol Surg. 2004;30:512-6.

Downloads

Published

18.11.2016

Issue

Section

Original Articles

How to Cite

1.
Comparative evaluation of hydroquinone, tretinoin and mometasone versus glycolic acid versus trichloroacetic acid peel in melasma. J Pak Assoc Dermatol [Internet]. 2016 Nov. 18 [cited 2026 Jul. 22];26(1):31-4. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/71